QLQiang Li

Qiang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qiang Li has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Peisheng Jin

    Center of Plastic and Aesthetic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China

    5 shared publications
  • Aijun Zhang

    Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

    3 shared publications
  • Dong Zhu

    Center for Cleft Lip and Palate Treatment, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China

    3 shared publications
  • Bingkun Zhao

    Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

    2 shared publications
  • Haoyu Wang

    Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

    2 shared publications
  • Jian Wang

    Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Macrophage efferocytosis promotes inflammation resolution and accelerates wound healing

    by Jia Gao, Dong Zhu, Jian Wang, Malak Ihtisham Ullah Khan, Aijun Zhang, Xiaokang Wen, Qiang Li, Peisheng Jin, Caiqi Shen

    Skin trauma, particularly chronic non-healing wounds, imposes significant economic and physical burdens on patients and their families. A defining feature of these wounds is persistent dysregulated inflammation, with macrophage efferocytosis playing a critical role. Efferocytosis-the programmed removal of apoptotic cells (ACs) by macrophages-is vital for resolving inflammation and facilitating tissue repair. In chronic wounds associated with systemic diseases such as diabetes, impaired macrophage efferocytosis hinders AC clearance, leading to prolonged inflammation and delayed healing. This review focuses on the molecular mechanisms regulating macrophage efferocytosis during inflammation and discusses clinical strategies to improve the healing of chronic wounds.


  • Open Access

    “Efficacy of Poly‐L‐Lactic Acid (PLLA) Injections in Treating Neck Wrinkles and Skin Quality in Chinese Women”

    by Yanping Guo, Zhao Wang, Xinzhu Long, Junsheng Chen, Aijun Zhang, Caiqi Shen, Qiang Li, Peisheng Jin

    Introduction: Poly‐L‐lactic acid (PLLA) is an injectable filler widely used for facial volume restoration, but its application for neck rejuvenation remains limited, particularly in Chinese women. Objective: To evaluate the safety and efficacy of PLLA in treating neck wrinkles, improving skin quality, and enhancing soft tissue support in Chinese women. Methods: This was a prospective, single‐center study conducted over 9 months, involving 40 women aged 24–61 with neck wrinkles graded 1–4 on the Allergan Transverse Neck Lines Scale (TNLS). The treatment involved linear‐threading and fanning cannula techniques. Key assessments included TNLS, 3D volumetric scanning, skin physiological parameters (elasticity, hydration, gloss, transepidermal water loss [TEWL], and pH), and the Global Aesthetic Improvement Scale (GAIS) at baseline, 1, 3, 6, and 9 months posttreatment. Results: During 9 months after treatment, TNLS scores significantly decreased from 2.78 ± 0.62 to 1.90 ± 0.63 ( p < 0.0001). Neck volume showed a significant increase of 4.41 ± 2.53 mm ( p < 0.0001). Skin quality, including hydration, TEWL, gloss, elasticity, and pH, improved to varying degrees ( p < 0.05 to p < 0.0001). GAIS scores demonstrated sustained improvement at all follow‐up points. Mild and transient adverse events were observed. Conclusion: PLLA injection effectively improves neck wrinkles and enhances skin quality in Chinese women. This treatment provides long‐lasting results with minimal adverse effects, making it a viable option for nonsurgical neck rejuvenation.

  • Open Access

    Alternative splicing: Therapeutic target for vasculopathy in diabetic complications

    by Xiaoyue Li, Dong Zhu, Bingkun Zhao, Qiang Li, Peisheng Jin


  • Open Access

    Nr-CWS regulates METTL3-mediated m6A modification of CDS2 mRNA in vascular endothelial cells and has prognostic significance

    by Jingyu Zhang, Feifei Chen, Wuhan Wei, Qianqian Ning, Dong Zhu, Jiang Fan, Haoyu Wang, Jian Wang, Aijun Zhang, Peisheng Jin, et al.

    Metabolic memory (MM) is a major factor in the delayed wound healing observed in diabetic patients. While “Nocardia rubrum cell wall skeleton” (Nr-CWS) is utilized to enhance macrophage proliferation in immune diseases, its impact on MM wounds in diabetes is unclear. This study demonstrates that transient hyperglycemia leads to prolonged damage in vascular endothelial cells by decreasing METTL3 expression, leading to decreased RNA methylation and impaired cellular metabolism. Remarkably, Nr-CWS application increases METTL3 levels in these cells, facilitating the recovery of cell function. Further in vivo and in vitro analyses demonstrate that transient hyperglycemia-induced reduction in METTL3 hinders RNA methylation of the downstream gene Cds2, impacting mitochondrial function and energy metabolism and consequently reducing angiogenic capacity in endothelial cells. This impairment significantly influences diabetic wound healing. Our findings highlight the profound impact of transient hyperglycemia on wound healing, establishing METTL3 as a significant role in vascular complications of diabetes. This study not only elucidates the pathophysiological mechanisms behind MM in diabetic wounds but also suggests Nr-CWS as a potential therapeutic agent, offering a novel approach for treating diabetic wounds.


  • N6-Methyladenosine Modification of lncCCKAR-5 Regulates Autophagy in Human Umbilical Cord Mesenchymal Stem Cells by Destabilizing LMNA and Inhibits Diabetic Wound Healing

    by Jian Wang, Xiaotian Wang, Feifei Chen, Qianqian Ning, YuTing Liu, Yun Zhu, Wuhan Wei, Mengqi Leng, Ziyi Wang, Peisheng Jin, et al.


  • Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

    by Jingyu Zhang, Bingkun Zhao, Wuhan Wei, Dan Wang, Haoyu Wang, Aijun Zhang, Changbo Tao, Xueyang Li, Qiang Li, Peisheng Jin

    With the development of society and the economy, the incidence of diabetic foot ulcers continues to increase. Currently, conventional debridement with dressing changes, hyperbaric oxygen, and vacuum sealing drainage are the main conservative treatments in clinical practice, and large wounds often require skin grafts or skin flap grafts. However, the treatment effects are not ideal, and many complications exist. Due to its complex pathogenesis, long treatment time, significant associated difficulties, and high disability rate, diabetic foot ulcers cause a heavy burden to patients, society, and medical care. According to our previous study, the pharmacological effects of human umbilical cord blood stem cells include nonspecific immune regulation; increased secretion of growth factors, vasoactive factors, and anti-inflammatory factors; enhanced anti-infectious ability of the human body; elimination of inflammation; and promotion of angiogenesis and ulcer healing. These effects suggest stem cells may be useful as an autologous or allogeneic treatment for refractory wounds. Therefore, we are conducting a clinical trial to treat refractory diabetic wounds with human umbilical cord stem cells in our clinic for diabetic foot ulcer patients who meet the inclusion criteria.


  • Genomic determinants of nested variant urothelial carcinoma.

    by Timothy Nguyen Clinton, Karissa Whiting, Vitor Silva, Qiang Li, Nima Almassi, Eugene Pietzak, Aditya Bagrodia, Eugene K. Cha, Guido Dalbagni, Gopa Iyer, et al.

    538 Background: Nested variant urothelial carcinoma (NVUC) is a historically aggressive variant of bladder cancer with management reliant on radical cystectomy given unclear effectiveness of chemotherapy. Given the aggressive behavior of NVUC, the identification of pathogenic and potentially targetable genomic alterations could suggest novel treatment paradigms for this rare histologic variant. Methods: Query of our institutional database identified 81 cases of clinically localized NVUC. Each case was re-reviewed by GU pathologists to confirm the histology. Targeted capture sequencing was performed to define the spectrum of genomic alterations in known and putative cancer genes. Clinical and sequencing data was then compared between the nested variant cases and a prospective cohort of clinically localized high-grade urothelial carcinomas, not otherwise specified (UC NOS). Results: On central re-review, tumors were classified as either classic NVUC (N=53) or high-grade urothelial carcinoma with nested features (N=28). A cohort of UC NOS patients (N=600) was used as a comparator. Median follow-up of the overall cohort was 4.3 years. Classic NVUC was associated with higher risk of cancer specific mortality compared to UC NOS on multivariate analysis (HR 1.76, p=0.04). Tumor mutational burden was lower in classic NVUC tumors versus UC NOS. Evaluation of 136 cancer-associated genes identified differences in mutational frequencies across the 3 cohorts (Table) with RhoA and FOXA1 alterations enriched in NVUC. Conclusions: Patients with NVUC have significantly higher risk of cancer specific mortality than patients with UC NOS. While there was significant overlap between the landscape of genomic alterations in NVUC and UC NOS tumors, NVUC tumors were enriched for RhoA and FOXA1 alterations among others.

  • Open Access

    Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells

    by Aihui Fan, Qian Wang, Yongjun Yuan, Jilun Cheng, Lixian Chen, Xiaohua Guo, Qiang Li, Bo Chen, Xuliang Huang, Qiaobing Huang

    Recent studies have shown that activation of liver X receptors (LXRs) attenuates the development of atherosclerosis, not only by regulating lipid metabolism but also by suppressing inflammatory signaling. Sphingosine 1-phosphate receptor 2 (S1PR2), an important inflammatory gene product, plays a role in the development of various inflammatory diseases. It was proposed that S1PR2 might be regulated by LXR-α. In the present study, the effect of LXR-α on tumor necrosis factor-α (TNF-α)-induced S1PR2 expression in human umbilical vein endothelial cells (HUVECs) was investigated and the underlying mechanism was explored. The results demonstrated that TNF-α led to an increase in S1PR2 expression and triggered a downregulation of LXR-α expression in HUVECs as well. Downregulation of LXR-α with specific small interfering RNA (siRNA) remarkably enhanced the primary as well as TNF-α-induced expression of S1PR2 in HUVECs. Activation of LXR-α by agonist GW3965 inhibited both primary and TNF-α-induced S1PR2 expression. GW3965 also attenuated S1PR2-induced endothelial barrier dysfunction. The data further showed that TNF-α induced a significant decrease in miR-130a-3p expression. Overexpression of miR-130a-3p with mimic product reduced S1PR2 protein expression, and inhibition of miR-130a-3p by specific inhibitor resulted in an increase in S1PR2 protein expression. Furthermore, activation of LXRs with agonist enhanced the expression of miR-130a-3p, and knockdown of LXR-α by siRNA suppressed miR-130a-3p expression. These results suggest that LXR-α might downregulate S1PR2 expression via miR-130a-3p in quiescent HUVECs. Stimulation of TNF-α attenuates the activity of LXR-α and results in enhanced S1PR2 expression.